Evidence map›Paper›PMID 38708277›Full record

ArticleACS omega2024

Leveraging Active Learning to Establish Efficient In Vitro Transcription and Translation from Bacterial Chromosomal DNA.

Leonardo Morini, Andrei Sakai, Mahesh A Vibhute, Zef Koch, Margo Voss, Ludo L J Schoenmakers, Wilhelm T S Huck

Abstract read
In one paragraph

Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Cell-free protein synthesis platforms for accelerating drug discovery.Biotechnology notes (Amsterdam, Netherlands) · 2025
    Review
  4. Synthetic biology (Oxford, England) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Leonardo MoriniInstitute for Molecules and Materials, Radboud University, Nijmegen 6525 AJ, The Netherlands.ORCID https://orcid.org/0000-0002-3862-6055
Andrei SakaiInstitute for Molecules and Materials, Radboud University, Nijmegen 6525 AJ, The Netherlands.ORCID https://orcid.org/0000-0002-2700-8059
Mahesh A VibhuteInstitute for Molecules and Materials, Radboud University, Nijmegen 6525 AJ, The Netherlands.ORCID https://orcid.org/0000-0002-5230-5290
Zef KochInstitute for Molecules and Materials, Radboud University, Nijmegen 6525 AJ, The Netherlands.
Margo VossInstitute for Molecules and Materials, Radboud University, Nijmegen 6525 AJ, The Netherlands.
Ludo L J SchoenmakersInstitute for Molecules and Materials, Radboud University, Nijmegen 6525 AJ, The Netherlands.ORCID https://orcid.org/0000-0002-6882-6840
Wilhelm T S HuckInstitute for Molecules and Materials, Radboud University, Nijmegen 6525 AJ, The Netherlands.ORCID https://orcid.org/0000-0003-4222-5411

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gene expression is a fundamental aspect in the construction of a minimal synthetic cell, and the use of chromosomes will be crucial for the integration and regulation of complex modules. Expression from chromosomes in vitro transcription and translation (IVTT) systems presents limitations, as their large size and low concentration make them far less suitable for standard IVTT reactions. Here, we addressed these challenges by optimizing lysate-based IVTT systems at low template concentrations. We then applied an active learning tool to adapt IVTT to chromosomes as template DNA. Further insights into the dynamic data set led us to adjust the previous protocol for chromosome isolation and revealed unforeseen trends pointing at limiting transcription kinetics in our system. The resulting IVTT conditions allowed a high template DNA efficiency for the chromosomes. In conclusion, our system shows a protein-to-chromosome ratio that moves closer to in vivo biology and represents an advancement toward chromosome-based synthetic cells.

Identifiers

PMID38708277
PMCPMC11064174

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.